| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |